Consumer Genomics Market 2028 Growing Worldwide By Best Key players- Ancestry; Gene By Gene, Ltd. (FamilyTree DNA); 23andMe, Inc.; Color Genomics, Inc; Myriad Genetics, Inc; Mapmygenome; Positive Biosciences, Ltd; Futura Genetics; Helix OpCo LLC; MyHeritage Ltd.; Pathway Genomics; Veritas
The global consumer
genomics market size is projected
to reach USD 8.1 billion by 2028,
according to a new report by Grand View Research, Inc. The market is expected
to expand at a CAGR of 19.4% from 2021
to 2028. Technological advances in genetic research have helped to raise
awareness among physicians as well as consumers pertaining to the use of
gene-based testing.
Genomics testing enables the
determination of common traits by studying a DNA molecule, predictions about
health, and offers evidence of a person’s ancestry. Several companies are
providing DNA tests directly to customers by which they have access to their
genetic information without involving the healthcare professional. Rising
awareness about DNA testing has driven the adoption rate, which in turn
provides healthy growth prospects for the implementation of DNA tests in home
settings.
The continuously declining costs of
genotyping have resulted in direct-to-consumer services becoming more
accessible to the average consumer as DNA testing services are delivered by key
companies. Many key participants are focusing majorly on building partnerships
and collaborations with physicians and healthcare systems to inflate their
current marketplace.
The Direct-to-Consumer (DTC) testing
market has significantly grown in the past few years due to the growing
interest of consumers and healthcare providers in personalized genetic
analysis. This is majorly due to the growing concerns pertaining to sedentary
lifestyles and poor diet-related illness among the global population.
Customers and physicians are adopting
genealogy services to gain knowledge about their ancestors and to locate family
members. The consumer gene testing companies are undertaking strategic
initiatives to grow awareness among consumers about genealogy testing. This, in
turn, has eventually developed genealogy testing, one of the key applications
of the consumer genomics field, to capture the wide interest of clinicians and
customers. This rise in awareness related to genealogy testing has resulted in
the increased adoption of consumer genomics.
To Request Sample Copy of this report, click the link:
https://www.grandviewresearch.com/industry-analysis/consumer-genomics-market/request/rs1
A rise in the adoption of consumer
genomics for COVID-19 research is anticipated to drive the market. In April
2020, AncestryDNA announced to use its consumer genomics database (with the
patient’s consent) to explore potential genetic cues for COVID-19. In July
2020, the study announced that the IVNS1ABP gene region in males is associated
with COVID-19 susceptibility. This also explained the harsh effects of the
viral disease in males as compared to females.
Consumer Genomics
Market Report Highlights
- The genetic relatedness segment accounted
for the largest revenue generation in 2020 and is anticipated to remain
dominant throughout the forecast period
- Genetic relatedness involves the
determination of hereditary or the genetic transfer of traits from parents
to their offspring
- These tests help analyze repetitive DNA
regions known as short tandem repeats for the determination of a
likelihood of paternity
- The lifestyle, wellness, and nutrition
segment is expected to witness the fastest CAGR as consumer genomics tests
are claimed to provide personalized nutrition based on an individual’s
genotype
- For patients with rare genetic disorders
such as galactosemia and lactose intolerance, a customized diet is
recommended
- Growing public interest for personalized
health has fueled the adoption of nutrigenetic testing services,
specifically for optimizing nutrition
- Hence, personalized nutrition is employed
to maintain or improve health by using genetic, clinical, and dietary
information to provide precise and more efficacious personalized healthy
recommendations
- North America is estimated to capture the
largest market share owing to the local presence of key industry
participants such as 23andMe and AncestryDNA, and the commercialization of
FDA approved kits
- Due to growing investments and skills, in
Asia Pacific, the market is expected to grow with the fastest CAGR
- This can majorly be attributed to the
advent of knowledge-based innovations and entry of investors focused on
personalized genetic screening as well as the presence of research funding
agencies
Expansion of the application areas of
DTC genetic tests is a high-impact rendering market driver. Genetic testing
involves a wide range of services such as data security, identification of
ancestors, race, and the nature of family, which increases its usage in
clinical practices. Thus, the adoption of genetic testing is increasing. In
addition, robust consumer genetics tests are used in clinical, genealogical,
and forensic areas. A large number of companies are offering DTC tests that
could be implemented in ongoing research, sports, nutrition, and other fields.
Companies such as 23andMe, bio.logis
Genetic Information Management (GIM) GmbH and DNA Testing Centers of Canada
deliver carrier screening tests kits in clinical settings. Similarly, My Gene
Diet, Smart DNA, and Halo Health International offer tailored diet services and
food plans. The trend of DTC personalized genomic testing is continuously
rising due to the low cost of different tests ranging from USD 99 to over USD
2000.
Furthermore, it does not require the
involvement of a healthcare provider. In addition, direct access to DTC genomic
test results will empower users to gain knowledge about themselves and assist
them in making proactive decisions, such as behavioral change and lifestyle.
Thus, these factors have led to the adoption of DTC personalized genomics. The
rapid growth of the genetic testing industry has also resulted in a higher
number of customers opting for online genetic testing.
List of Key
Players of Consumer Genomics Market
- Ancestry
- Gene By Gene, Ltd. (FamilyTree DNA)
- 23andMe, Inc.
- Color Genomics, Inc
- Myriad Genetics, Inc
- Mapmygenome
- Positive Biosciences, Ltd
- Futura Genetics
- Helix OpCo LLC
- MyHeritage Ltd.
- Pathway Genomics
- Veritas
- Amgen, Inc.
- Xcode Life
Comments
Post a Comment